Kcit (1500 mg+250 mg)/5 ml (Oral Solution)
Medicine Details
| Category | Details |
|---|---|
| Generic | Potassium citrate citric acid |
| Company | Navana pharmaceuticals ltd |
Indications
- Relief of discomfort in urinary tract infections
- Prevention of kidney stones
- Prevention of gout with uricosuric agent
- Treatment of acidosis caused by kidney diseases
Pharmacology
Potassium Citrate and Citric Acid oral solution is a stable and pleasant-tasting oral systemic alkalizer. It alkalinizes urine without causing systemic alkalosis. It is highly palatable and tolerable even when used for long periods. Does not neutralize gastric juice or disturb digestion.
Dosage & Administration
- Relief of discomfort in UTI:
- Adults and children over 6 years: 10 ml 3 times daily, diluted with 1 glass of water
- Children 1-6 years: 5 ml 3 times daily, diluted with ½ glass of water
- Prevention of kidney stones, Gout prevention, Acidosis treatment:
- Adults: 10-15 ml 4 times daily (or as directed by physician), diluted with 1 glass of water
- Pediatric: 5-10 ml 4 times daily (or as directed by physician), diluted with ½ glass of water
Interaction
Concurrent administration of potassium-containing medication, potassium-sparing diuretics, ACE inhibitors, or cardiac glycosides may lead to toxicity
Contraindications
Severe renal impairment with oliguria or azotemia, untreated Addison's disease, acute dehydration, severe myocardial damage, hyperkalemia from any cause
Side Effects
Well tolerated in patients with normal renal function and urinary output. Caution should be used in patients with abnormal renal mechanisms to avoid hyperkalemia or alkalosis.
Pregnancy & Lactation
No information available regarding use during pregnancy and lactation
Precautions & Warnings
Use with caution in patients with low urinary output. Dilute with water to minimize gastrointestinal injury. Take each dose after meals to avoid hyperkalemia and alkalosis.
Overdose Effects
May cause serious hyperkalemia in persons with impaired excretory mechanisms. Treatment measures include elimination of potassium-containing foods or medications, intravenous administration of dextrose solution with insulin, and use of exchange resins, hemodialysis, or peritoneal dialysis.
Therapeutic Class
- Prevention of repeated kidney stone formation
- Urinary Alkalinizing Agent
Storage Conditions
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Related Brands
- Ural-K (1500 mg+250 mg)/5 ml (Oral Solution) - beximco-pharmaceuticals-ltd
- Alken (1500 mg+250 mg)/5 ml (Oral Solution) - al-madina-pharmaceuticals-ltd
- Urocid-N (1500 mg+250 mg)/5 ml (Oral Solution) - one-pharma-ltd
- Urokool (1500 mg+250 mg)/5 ml (Oral Solution) - opsonin-pharma-ltd
- Urosolv (1500 mg+250 mg)/5 ml (Oral Solution) - edruc-limited